Among EGFR ligands, amphiregulin, even if has lower binding affinity for EGFR than EGF or TGFα, is highly expressed in different tumours, such as breast cancer or hepatocellular carcinoma, contributing to the transformed phenotype 17, 18. This evidence concerns the gene AREG and breast carcinoma.